We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IGMS
2451
DELISTED
IGM Biosciences
IGMS
$924K ﹤0.01%
40,633
+1,900
+5% +$38.4K
MGMT icon
2452
Ballast Small/Mid Cap ETF
MGMT
$177M
$924K ﹤0.01%
+31,818
New +$1.01M
TRMK icon
2453
Trustmark
TRMK
$2.81B
$923K ﹤0.01%
30,138
+6,148
+26% +$195K
BEP icon
2454
Brookfield Renewable
BEP
$10.5B
$921K ﹤0.01%
29,427
-6,413
-18% -$237K
CGBD icon
2455
Carlyle Secured Lending
CGBD
$783M
$921K ﹤0.01%
80,466
-4,713
-6% -$64K
BGR icon
2456
BlackRock Energy and Resources Trust
BGR
$430M
$920K ﹤0.01%
85,378
+2,630
+3% +$29.4K
HGLB
2457
Highland Global Allocation Fund
HGLB
$178M
$919K ﹤0.01%
105,433
+16,706
+19% +$167K
REET icon
2458
iShares Global REIT ETF
REET
$5.1B
$918K ﹤0.01%
43,147
+3,428
+9% +$84.5K
EWL icon
2459
iShares MSCI Switzerland ETF
EWL
$2.21B
$916K ﹤0.01%
24,455
+16,463
+206% +$681K
RVTY icon
2460
Revvity
RVTY
$13B
$915K ﹤0.01%
7,603
-74
-1% -$10.4K
JQUA icon
2461
JPMorgan US Quality Factor ETF
JQUA
$8.63B
$912K ﹤0.01%
26,039
+2,717
+12% +$105K
MXL icon
2462
MaxLinear
MXL
$7.35B
$912K ﹤0.01%
27,957
+5,887
+27% +$218K
BSJO
2463
DELISTED
Invesco BulletShares 2024 High Yield Corporate Bond ETF
BSJO
$911K ﹤0.01%
42,126
-72
-0.2% -$1.61K
SGRY icon
2464
Surgery Partners
SGRY
$2B
$909K ﹤0.01%
38,845
+348
+0.9% +$11.1K
BOOT icon
2465
Boot Barn
BOOT
$4.96B
$906K ﹤0.01%
15,498
+3,370
+28% +$226K
ENLC
2466
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$904K ﹤0.01%
101,734
+34,540
+51% +$332K
SYNA icon
2467
Synaptics
SYNA
$4.21B
$903K ﹤0.01%
9,122
+60
+0.7% +$7.45K
PPH icon
2468
VanEck Pharmaceutical ETF
PPH
$983M
$901K ﹤0.01%
13,400
+40
+0.3% +$2.95K
HAE icon
2469
Haemonetics
HAE
$4.13B
$900K ﹤0.01%
12,154
-17,104
-58% -$1.23M
FPL
2470
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
$896K ﹤0.01%
163,514
-1,521
-0.9% -$9.27K
IGPT icon
2471
Invesco AI and Next Gen Software ETF
IGPT
$1.2B
$895K ﹤0.01%
30,228
+561
+2% +$18.3K
LEVI icon
2472
Levi Strauss
LEVI
$8.58B
$894K ﹤0.01%
61,758
+25,461
+70% +$454K
FROG icon
2473
JFrog
FROG
$11.8B
$892K ﹤0.01%
40,337
-1,686
-4% -$37.6K
IIPR icon
2474
Innovative Industrial Properties
IIPR
$1.65B
$890K ﹤0.01%
10,057
-2,378
-19% -$231K
XSLV icon
2475
Invesco S&P SmallCap Low Volatility ETF
XSLV
$251M
$886K ﹤0.01%
21,838
-2,056
-9% -$93.3K

Similar funds

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.